Research Study

A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer
Principal Investigator 
Peter Black

Overview

Body Locations and Systems 
Cancer
Disorders and Conditions 
Bladder Cancers
ClinicalTrials.gov# 
nct01224665
Status 
Closed to Recruitment
Study Start/End 
Feb 28, 2013 to Feb 28, 2019
Locations 
Diamond Health Care Centre, Vancouver General Hospital
Name/Title 
Maureen Palmer, Study Coordinator
Phone 
604-875-5675
Purpose of Study 

RATIONALE: Lymphadenectomy may remove tumor cells that have spread to nearby lymph nodes in patients with invasive bladder cancer. It is not yet known whether extended pelvic lymphadenectomy is more effective than standard pelvic lymphadenectomy during surgery.

PURPOSE: This randomized phase II trial is studying standard pelvic lymphadenectomy to see how well it works compared to extended pelvic lymphadenectomy in treating patients undergoing surgery for invasive bladder cancer.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.